Kind of unfortunate timing to have to put out the 4C so close to funding, but it is what it is.
I like the fact major shareholders are the likely participants in the upcoming deal. Let's hope AstraZen also has a role to play - will represent significant validation of Jeremy's strategy going forward. Nonetheless the devil will be in the detail. I doubt this will be a long wait.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
Kind of unfortunate timing to have to put out the 4C so close to...
Featured News
Add ADR (ASX) to my watchlist
|
|||||
Last
1.4¢ |
Change
-0.002(12.5%) |
Mkt cap ! $10.62M |
Open | High | Low | Value | Volume |
1.5¢ | 1.5¢ | 1.4¢ | $2.688K | 186.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 269000 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 28527 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 269000 | 0.015 |
5 | 404620 | 0.014 |
3 | 265520 | 0.013 |
3 | 246580 | 0.012 |
2 | 696818 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 28527 | 1 |
0.017 | 432462 | 1 |
0.019 | 99985 | 1 |
0.020 | 120000 | 1 |
0.021 | 391000 | 2 |
Last trade - 10.10am 09/08/2024 (20 minute delay) ? |
Featured News
ADR (ASX) Chart |